ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Pfizer acquires Therachon to broaden its rare disease pipeline pharmaceutical-technology
May 23, 2019Pfizer has entered into a definitive agreement to acquire all shares of Therachon, a private clinical-stage biotechnology company focused on rare diseases with pipeline assets in achondroplasia and short bowel syndrome therapies.
Pharma Sources Insight January 2025
